View in EDS HTML Full Text PDF Full Text

Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis.

Saved in:
Bibliographic Details
Title: Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis.
Authors: Pavlakis, Evangelos1 (AUTHOR), Neumann, Michelle1 (AUTHOR), Merle, Nastasja1 (AUTHOR), Wieboldt, Ronja1 (AUTHOR), Wanzel, Michael1,2 (AUTHOR), Ponath, Viviane3 (AUTHOR), Pogge von Strandmann, Elke3 (AUTHOR), Elmshäuser, Sabrina1 (AUTHOR), Stiewe, Thorsten1,2,4,5 (AUTHOR) stiewe@uni-marburg.de
Source: Journal of Experimental & Clinical Cancer Research (17569966). 8/10/2023, Vol. 42 Issue 1, p1-21. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first